Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM43T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,845
Award facts
- Contract value 100% obligated
- $98,845.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $98,845.40 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 ml syringes on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement. The company demonstrates substantial capability in fulfilling diverse pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its established IDC with DLA. Cencora, Inc. itself maintains a significant single-award IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, further demonstrating the corporate group's central role in supplying essential pharmaceutical commodities to military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM43T?
SPE2DR26FM43T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FM43T worth?
The government has obligated $98,845 on SPE2DR26FM43T.
Is contract SPE2DR26FM43T an order under another contract?
Yes. SPE2DR26FM43T is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM43T competed?
The extent of competition for SPE2DR26FM43T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award